For instance, a study conducted by Anholm et al. showed that in patients with stable CAD and newly diagnosed T2D receiving standard statin therapy, liraglutide in combination with metformin improved lipid profile and reduced C-reactive protein (CRP) blood levels [147]. This evidence concerns the gene CRP and type 2 diabetes mellitus.